Read More Pharma Industry News Y-mAbs Therapeutics showcases promising CD38-SADA translational pharmacokinetics data at AACR 2025 Find out how Y-mAbs’ CD38-SADA translational pharmacokinetics study at AACR 2025 is advancing next-gen cancer therapies with promising clinical insights. byPallavi MadhirajuApril 28, 2025